B2 预后指数用于确定转移性乳腺癌的预后
Mehmet Meric Coban1,2, Mehmet Uzun, Tugba Yavuzsen
1Department of Internal Medicine, Dokuz Eylul University, Izmir, Turkiye.
概括
B2预后指数 (B2PI) 有效预测转移性乳腺癌患者的生存率. 这种工具有助于制定治疗策略,通过将患者分为不同风险群体进行分层,以获得更好的预后.
科学领域:
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 转移性乳腺癌 (MBC) 带来了重大的生存挑战.
- 预后指数对于指导MBC治疗决策至关重要.
研究的目的:
- 评估B2预后指数 (B2PI) 与转移性乳腺癌的预后相关.
- 使用易于获取的临床参数开发B2PI的实用公式.
主要方法:
- 在176名女性乳腺癌患者 (111名新发转移) 上进行了一项描述性研究.
- 两组之间的临床病理学特征进行了比较.
- 卡普兰-梅尔分析和考克斯回归被用来评估整体生存和死亡风险因素.
主要成果:
- 在B2PI中,除了HER2+ ER-之外,大多数内在亚型的风险组的整体存活率存在显著差异.
- 根据B2PI分类为低风险和中等风险的患者与高风险患者相比,平均整体存活时间更长.
- B2PI评分系统在区分生存结果方面证明是有效的.
结论:
- 该B2PI作为一个有价值的临床决策工具用于转移性乳腺癌.
- 它有助于预后的确定和开发量身定制的治疗策略.
- 该指数使用了临床实践中容易获得的参数.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.3K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
248
相关概念视频
Cancer Survival Analysis
340
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
340
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
